Loading clinical trials...
Loading clinical trials...
A Phase 1/2, Randomized, Stratified, Observer-Blind, Dose-Ranging Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults 18 Years and Older
Conditions
Interventions
mRNA-1010
Placebo
+1 more
Locations
21
United States
Cognitive Clinical Trials - Phoenix
Phoenix, Arizona, United States
Alliance for Multispecialty Research, LLC - Phoenix
Tempe, Arizona, United States
Benchmark Research - Colton, CA
Colton, California, United States
Research Centers of America - ERGG - PPDS
Hollywood, Florida, United States
Meridian Clinical Research (Savannah Georgia) - Platinum - PPDS
Savannah, Georgia, United States
Meridian Clinical Research
Sioux City, Iowa, United States
Start Date
July 6, 2021
Primary Completion Date
September 27, 2022
Completion Date
September 27, 2022
Last Updated
October 27, 2023
NCT06602024
NCT05827978
NCT05827068
NCT05245552
NCT05333289
NCT05512494
Lead Sponsor
ModernaTX, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions